Tag Archives: psychedelics

The past few years have witnessed astonishing growth in commercial interest in the use of psychedelics for treatment of a variety of unmet medical needs, particularly mental health disorders.  With that growth has come an increase in patent filings as companies seek to protect their investments.  IP protection for psychedelics and psychedelic-related compounds shares many […]

Last month we wrote about a recent registration of the term PSILOCYBIN for educational materials related to psychoactive plants. The point of our article was that applying for generic terms as trademarks is not the most effective strategy for developing a distinctive brand. Now, sadly, a flurry of coronavirus-related trademark applications raises similar concerns. In a […]

In contrast to medical science’s aggressive pursuit of new therapeutics for cancers, cardiovascular disorders, or infectious disease, the discovery of new therapeutics for mental health has lagged. But, the past few years have witnessed renewed interest in the development of psychedelic therapeutics for treatment of unmet medical needs in mental health. The astonishing growth of a […]